Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, CHC Healthcare Group's Enterprise Value is NT$9,347 Mil.
CHC Healthcare Group's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was NT$-93 Mil. Therefore, CHC Healthcare Group's EV-to-FCF for today is -100.28.
The historical rank and industry rank for CHC Healthcare Group's EV-to-FCF or its related term are showing as below:
TPE:4164'
s EV-to-FCF Range Over the Past 10 Years
Min: -650.09 Med: 31.92 Max: 573.9
Current: -100.17
During the past 13 years, the highest EV-to-FCF of CHC Healthcare Group was 573.90. The lowest was -650.09. And the median was 31.92.
TPE:4164's EV-to-FCF is ranked worse than 100% of 72
companies
in the Medical Distribution industry
Industry Median: 17.36
vs TPE:4164: -100.17
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CHC Healthcare Group (TPE:4164) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CHC Healthcare Group's PE Ratio (TTM) for today is calculated as:
CHC Healthcare Group's share price for today is NT$26.05.
CHC Healthcare Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.030.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
CHC Healthcare Group EV-to-FCF Related Terms
CHC Healthcare Group EV-to-FCF Historical Data
* Premium members only.
The historical data trend for CHC Healthcare Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, CHC Healthcare Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CHC Healthcare Group EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, CHC Healthcare Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where CHC Healthcare Group's EV-to-FCF falls into.
CHC Healthcare Group's current Enterprise Value is NT$9,347 Mil.
CHC Healthcare Group's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHC Healthcare Group (TPE:4164) has a EV-to-FCF of -100.28 as of Aug. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on CHC Healthcare Group and its competitors. According to the industry distribution chart, CHC Healthcare Group ranks #999999 out of 72 companies in the Medical Distribution industry.
Is CHC Healthcare Group's EV-to-FCF too high?
CHC Healthcare Group's current EV-to-FCF is -100.28. Based on the distribution chart, CHC Healthcare Group ranks #999999 out of 72 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, CHC Healthcare Group has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CHC Healthcare Group's EV-to-FCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, CHC Healthcare Group ranks #999999 out of 72 companies for EV-to-FCF. This places CHC Healthcare Group in the lower half of its industry. The industry median EV-to-FCF is 17.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 17.36, based on 72 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on CHC Healthcare Group and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 17.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CHC Healthcare Group's current EV-to-FCF is -100.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CHC Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, CHC Healthcare Group (TPE:4164) is currently considered Possible Value Trap. The stock's GF Value™ is NT$52.32, compared to a current price of NT$26.05 — trading 50.2% below its estimated fair value. The current EV-to-FCF is -100.28. CHC Healthcare Group's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For CHC Healthcare Group (TPE:4164), the current EV-to-FCF is -100.28 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CHC Healthcare Group (TPE:4164) Overvalued in 2026?
Based on GuruFocus' analysis, CHC Healthcare Group stock appears to be undervalued.
The current stock price of NT$26.05 is trading 50.2% below its estimated GF Value™ of NT$52.32.
GuruFocus considers CHC Healthcare Group to be Possible Value Trap.
Key valuation signals for TPE:4164:
EV-to-FCF: -100.28
GF Value™: NT$52.32 vs. price of NT$26.05 (50.2% below fair value)
No single metric tells the full story. See the TPE:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and health food, as well as the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment used in radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, the sale of medical instruments, repairs, maintenance, and other services.
76GF Score
Get the complete analysis for TPE:4164
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4164 has been successfully added to your 
